English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Aim. Primary morbidity and prevalence of prostate disorders and cancer in population of Moscow in 2006—2015 have been studied in comparison with the Russian Federation. Material and methods. The trends of the incidence and prevalence of prostatic diseases and cancer in population of Moscow, as compared to the Russian Federation, have been analyzed in the article, based on the official statistical reports for 2006—2015. Results and discussion. Diseases of the prostate gland constitute the largest proportion of all urological diseases in the structure of morbidity and prevalence of the diseases of the genitourinary system in Moscow. It was shown that the trends in the incidence and prevalence of prostate diseases among residents of the capital do not match the characteristics of dynamics of similar indicators in the Russian Federation, which might be related to the lack of diagnosis and deterioration in organization of dispensary monitoring of these patients in Moscow. It has been established that prostate gland is the most frequent substrate for malignant tumors in the structure of all oncological diseases revealed in inhabitants of the capital. Prostate cancer is also the most frequent cause of death. Among all oncological diseases the highest rate of increase in the incidence rate (by 33,6%) and mortality (by 14,6%) during 2006—2015 was seen in patients with prostate cancer. The effectiveness of targeted oncological examinations, the timeliness of prostate cancer detection and the effectiveness of treatment in Moscow are higher than in the Russian Federation as a whole. However, even in the capital, the indicators of active

MODERN MORBIDITY TRENDS FROM PROSTATE DISORDERS IN POPULATION OF MOSCOW